FOXO3 and myeloproliferative neoplasm: In addition, they showed that JAK2V617F-positive erythroblasts derived from myeloproliferative neoplasm patients also displayed the increased ROS level and reduced nuclear FOXO3 compared with the control erythroblasts [90].